US2014162343A1PendingUtilityA1
Sporulation-deficient b. texasporus cells and methods for efficient and cost-effective inactivation and use thereof
Est. expiryMar 1, 2031(~4.6 yrs left)· nominal 20-yr term from priority
Inventors:Yiwei Jiang
A61P 3/10A61P 33/02A61P 31/12A61P 3/04A61P 31/16A61P 31/14A61P 31/04A61P 3/00A61P 13/02A61P 11/00A61P 1/00C12N 1/36A61K 35/742C12N 1/20A23L 29/00C12R 2001/07C12N 1/205Y02A50/30
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Novel strains and methods for their use are provided. Particularly, foods and other oral products or treatments containing sporulation-deficient Brevibacillus strain when administered to a subject can inhibit or reduce the number of pathogens in the subject and improve the health of the subject.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A sporulation-deficient B. texasporus strain having a survival rate less than about 3.5×10 −3 , wherein sporulation-deficiency may be measured by subjecting a culture to a temperature of about 50° C. for about 5 minutes and measuring the survival rate.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.